05 Dec 2025

Kirkland & Ellis Advises Kestra Medical Technologies on $158.7 Million Upsized Public Offering

"Kirkland & Ellis advised Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) on an upsized underwritten public offering of 6.9 million common shares at $23.00 per share, raising $158.7 million. The offering closed on December 4, 2025."

Kirkland & Ellis represented Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) in connection with the transaction. Kestra Medical Technologies, a wearable medical device and digital healthcare company, completed an upsized underwritten public offering of 6.9 million common shares at a price to the public of $23.00 per share, generating total proceeds of $158.7 million. The offering closed on December 4, 2025. Kirkland & Ellis represented Kestra Medical Technologies, Ltd. with a team composed by: capital markets lawyers Sophia Hudson, Christie Mok, Sandy Park and Clara Lang; technology & IP transactions lawyer Matt Darch; tax lawyer Leah Warren; and investment funds regulatory lawyer Phil Giglio.
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.